We show that, in a tumor model where there is a pre-existing, weak/immuno-subdominant anti-HCCTAA CD8+ T cell response, addition of a highly immuno-dominant oncolytic virus effectively occluded the anti-tumor response with a rapid effector anti-viral CD8+ T cell response. Here, CD8A is linked to neoplasm.